S. Khan, M. Toledano, and S. Taylor-robinson, Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma, HPB, vol.10, issue.2, pp.77-82, 2008.
DOI : 10.1080/13651820801992641

J. Everhart and C. Ruhl, Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas, Gastroenterology, vol.136, issue.4, pp.1134-1144, 2009.
DOI : 10.1053/j.gastro.2009.02.038

R. Dodson, M. Weiss, and D. Cosgrove, Intrahepatic Cholangiocarcinoma: Management Options and Emerging Therapies, Journal of the American College of Surgeons, vol.217, issue.4, pp.736-750, 2013.
DOI : 10.1016/j.jamcollsurg.2013.05.021

S. Mouli, K. Memon, and T. Baker, Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1227-1234, 2013.
DOI : 10.1016/j.jvir.2013.02.031

S. Rafi, S. Piduru, and B. El-rayes, Yttrium-90 Radioembolization for Unresectable Standard-chemorefractory Intrahepatic Cholangiocarcinoma: Survival, Efficacy, and Safety Study, CardioVascular and Interventional Radiology, vol.22, issue.2, pp.440-448, 2013.
DOI : 10.1007/s00270-012-0463-4

R. Hoffmann, P. Paprottka, and A. Schön, Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival, CardioVascular and Interventional Radiology, vol.11, issue.33, pp.105-116, 2012.
DOI : 10.1007/s00270-011-0142-x

A. Saxena, L. Bester, and T. Chua, Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option, Annals of Surgical Oncology, vol.16, issue.9493, pp.484-491, 2010.
DOI : 10.1245/s10434-009-0777-x

D. Al-adra, R. Gill, and S. Axford, Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis, European Journal of Surgical Oncology (EJSO), vol.41, issue.1, pp.120-127, 2015.
DOI : 10.1016/j.ejso.2014.09.007

J. Edeline, F. Du, and M. Rayar, Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma, Clinical Nuclear Medicine, vol.40, issue.11, pp.10-1097, 2015.
DOI : 10.1097/RLU.0000000000000904

URL : https://hal.archives-ouvertes.fr/hal-01187323

E. Eisenhauer, P. Therasse, and J. Bogaerts, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 2009.
DOI : 10.1016/j.ejca.2008.10.026

S. Ibrahim, P. Nikolaidis, and F. Miller, Radiologic findings following Y90 radioembolization for primary liver malignancies, Abdominal Imaging, vol.37, issue.Suppl 1, pp.566-581, 2009.
DOI : 10.1007/s00261-008-9454-y

J. Camacho, N. Kokabi, and M. Xing, Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following Yttrium-90 Radioembolization, Journal of Vascular and Interventional Radiology, vol.25, issue.2, p.90, 2014.
DOI : 10.1016/j.jvir.2013.10.056

H. Choi, C. Charnsangavej, and S. De-castro-faria, A Quantitative Analysis Correlated with FDG PET Findings, American Journal of Roentgenology, vol.183, issue.6, pp.1619-1628, 2004.
DOI : 10.2214/ajr.183.6.01831619

M. Ronot, M. Bouattour, and J. Wassermann, Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib, The Oncologist, vol.19, issue.4, pp.394-402, 2014.
DOI : 10.1634/theoncologist.2013-0114

Z. Weng, J. Ertle, and S. Zheng, Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma, Oncol Lett, vol.6, pp.1707-1712, 2013.

R. Salem, R. Lewandowski, and V. Gates, Research Reporting Standards for Radioembolization of Hepatic Malignancies, Journal of Vascular and Interventional Radiology, vol.22, issue.3, pp.265-278, 2011.
DOI : 10.1016/j.jvir.2010.10.029

E. Garin, L. Lenoir, and Y. Rolland, Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach, Nuclear Medicine Communications, vol.32, issue.12, pp.1245-1255, 2011.
DOI : 10.1097/MNM.0b013e32834a716b

URL : https://hal.archives-ouvertes.fr/hal-00739618

J. Kalkmann, M. Zeile, and G. Antoch, Consensus report on the radiological management of patients with gastrointestinal stromal tumours (GIST): recommendations of the German GIST Imaging Working Group, Cancer Imaging, vol.12, issue.1, pp.126-135, 2012.
DOI : 10.1102/1470-7330.2012.0013

J. Bruix, M. Sherman, and J. Llovet, Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference, Journal of Hepatology, vol.35, issue.3, pp.421-430, 2001.
DOI : 10.1016/S0168-8278(01)00130-1

V. Goh, S. Halligan, and A. Gharpuray, Quantitative Assessment of Colorectal Cancer Tumor Vascular Parameters by Using Perfusion CT: Influence of Tumor Region of Interest, Radiology, vol.247, issue.3, pp.726-732, 2008.
DOI : 10.1148/radiol.2473070414